Gayron Kenneth L 4
4 · KIORA PHARMACEUTICALS INC · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Gayron Kenneth L
Director
Transactions
- Award
Stock Option (right to buy)
2023-09-29+5,000→ 5,000 totalExercise: $0.57Exp: 2033-09-29→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024.